Aura Biosciences, Inc. (AURA)
6.56
+0.27
(+4.29%)
USD |
NASDAQ |
Oct 20, 16:00
6.565
0.00 (0.00%)
After-Hours: 20:00
Aura Biosciences EPS Diluted (Quarterly) : -0.4811 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4811 |
| March 31, 2026 | -0.4994 |
| December 31, 2025 | -0.4019 |
| September 30, 2025 | -0.3963 |
| June 30, 2025 | -0.4657 |
| March 31, 2025 | -0.5483 |
| December 31, 2024 | -0.518 |
| September 30, 2024 | -0.4237 |
| June 30, 2024 | -0.4104 |
| March 31, 2024 | -0.3985 |
| December 31, 2023 | -0.498 |
| September 30, 2023 | -0.4848 |
| June 30, 2023 | -0.4834 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.4623 |
| December 31, 2022 | -0.5198 |
| September 30, 2022 | -0.5432 |
| June 30, 2022 | -0.4604 |
| March 31, 2022 | -0.4394 |
| December 31, 2021 | -0.4433 |
| September 30, 2021 | -0.4281 |
| June 30, 2021 | -0.4271 |
| March 31, 2021 | -0.2826 |
| December 31, 2020 | -0.2406 |
| September 30, 2020 | -0.191 |
| June 30, 2020 | -0.2766 |
| March 31, 2020 | -0.323 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -45.64M |
| Total Expenses (Quarterly) | 45.64M |
| Enterprise Value | 371.58M |
| Earnings Yield | -27.11% |
| Normalized Earnings Yield | -27.11 |